Recipient and donor factors influence the incidence of graft-vs.host disease in liver transplant patients

Liver Transplantation

Volumn 13, Issue 4, 2007, Pages 516-522

  Chan, Edie Y ^a   Larson, Anne M ^b   Gernsheimer, Terry B ^b   Kowdley, Kris V ^b   Carithers Jr , Robert L ^b   Reyes, Jorge D ^a   Perkins, James D ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ALCOHOL LIVER DISEASE; ARTICLE; AUTOIMMUNE HEPATITIS; CONTROLLED STUDY; DATA BASE; DISEASE SEVERITY; FATTY LIVER; FEMALE; GENDER; GLUCOSE INTOLERANCE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HIGH RISK POPULATION; HLA MATCHING; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORGAN DONOR; PRIORITY JOURNAL; SURVIVAL;

GRAFT VS HOST DISEASE; HUMANS; LIVER TRANSPLANTATION; RISK FACTORS; TISSUE DONORS;

EID: 34247239342     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21082     Document Type: Article

References (58)

1. Taylor AL, Gibbs P, Bradley JA. Acute graft versus host disease following liver transplantation: the enemy within. Am J Transplant 2004;4:466-474.
2. Smith DM, Agura E, Netto G, Collins R, Levy NM, Goldstein R, et al. Liver transplant-associated graft-versus-host disease. Transplantation 2003;75:118-126.
3. Taylor AL, Gibbs P, Sudhindran S, Key T, Goodman RS, Morgan CH, et al. Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease after liver transplantation. Transplantation 2004; 77:441-446.
4. Burdick JF, Vogelsang GB, Smith WJ, Farmer ER, Bias WB, Kaufmann SH, et al. Severe graft-versus-host disease in a liver-transplant recipient. N Engl J Med 1988:318: 689-691.
5. Schmuth M, Vogel W, Weinlich G, Margretter R, Fritsch P, Sepp N. Cutaneous lesions as the presenting sign of acute graft-versus-host disease following liver transplantation. Br J Dermatol 1999; 141:901-904.
6. Domiati-Saad R, Klintmalm GB, Netto G, Agura ED, Chinnakotla S, Smith DM. Acute graft versus host disease after liver transplantation: patterns of lymphocyte chimerism. Am J Transplant 2005;5:2968-2973.
7. Firoz BF, Lee SJ, Nghiem P, Qureshi AA. Role of skin biopsy to confirm suspected acute graft-vs-host disease. Arch Dermatol 2006; 142:175-182.
8. Hahn AB, Baliga P. Rapid method for the analysis of peripheral chimerism in suspected graft-versus-host disease after liver transplantation. Liver Transpl 2000;6:180-184.
9. Arrieta A, Maruri N, Riñón M, Fernández JR, Ortiz de Urbina J, Garcia Masdevall MD. Confirmation of graft-versus-host disease by HLA typing after liver transplantation. Transplant Proc 2002; 34:278-279.
10. Au WY, Ma SK, Kwong YL, Ng IOL, Hawkins BR, Wan TSK, et al. Graft-versus-host disease after liver transplantation: documentation by fluorescent in situ hybridization and human leucocyte antigen typing. Clin Transplant 2000; 14:174-177.
11. Aziz H, Trigo P, Lendoire J, Bianco G, Saúl, Braslavsky G, et al. Successful treatment of graft-vs-host disease after a second liver transplant. Transplant Proc 1998;30:2891-2892.
12. Collins Jr RH, Cooper B, Nikaein A, Mintmahn G, Fay JW. Graft-versus-host disease in a liver transplant recipient. Ann Intern Med 1992; 116:391-392.
13. Collins RH, Anastasi J, Terstappen L, Nikaein A, Feng J, Fay JW, et al. Donor-derived long-term multilineage hematopoiesis in a liver-transplant recipient. N Engl J Med 1993;328:762-765.
14. DePaoli AM, Bitran J. Graft-versus-host disease and liver transplantation. Ann Intern Med 1992; 117:170.
15. DuMortier J, Souraty P, Bernard P, Scoazec JY, Berger F, Euvrard S, Boillot O. Réaction du greffon contre l'hôte après transplantation hépatique: guérison après introduction du tacrolimus. Gastroenterol Clin Biol 2003;27: 561-562.
16. Hanaway MJ, Buell JF, Musat AI, Kalayoglu M. Graft-versus-host disease in solid organ transplantation. Graft 2001;4:205-208.
17. Hara. H, Ohdan H, Tashiro H, Itamoto T, Tanaka Y, Mizunuma K, et al. Differential diagnosis between graft-verus-host disease and hemophagocytic syndrome after living-related liver transplantation by mixed lymphocyte reaction assay. J Invest Surg 2004; 17:197-202.
18. Jamieson NV, Joysey V, Friend PJ, Marcus R, Ramsbottom S, Baglin T, et al. Graft-versus-host disease in solid organ transplantation. Transpl Int 1991;4:67-71.
19. Joseph JM, Mosimann F, Tiercy JM, Roux E, Cerottini JP, Gillet M, Aubert V. PCR confirmation of microchimerism and diagnosis of graft versus host disease after liver transplantation. Transpl Int 1999:12:468-470.
20. Joysey VC, Wood H, Ramsbottom S, Morgan H, Ford C, Horsford J, et al. Lymphocyte chimaerism after organ transplantation. Transplant Proc 1992;24:2519-2522.
21. Knox KS, Behnia M, Smith LR, Vance GH, Busk M, Cummings OW, et al. Acute graft-versus-host disease of the lung after liver transplantation. Liver Transpl 2002;8:968-971.
22. Kuball J, Theobald M, Ferreira EA, Hess G, Burg J, Maccagno G, et al. Control of organ transplant-associated graft-versus-host disease by activated host lymphocyte infusions. Transplantation 2004;78:1774-1779.
23. Lehner F, Becker T, Sybrecht L, Lück R, Schwinzer R, Slateva K, et al. Successful outcome of acute graft-versus-host disease in a liver allograft recipient by withdrawal of immunosuppression. Transplantation 2002;73:307-310.
24. Marubayashi S, Matsuzaka C, Takeda A, Cost MM, Jamieson NV, Joysey V, Calne RY. Fatal generalized acute graft-versus-host disease in a liver transplant recipient. Transplantation 1990;50:709-711.
25. Mazzaferro V, Andreola S, Regalia E, Poli F, Doci R, Bozzetti F, Gennari L. Confirmation of graft-versus-host disease after liver transplantation by PCR HLA-typing. Transplantation 1993;55:423-458.
26. Merhav JH, Landau M, Gat A, Gazit E, Baratz M, Bialy-Golan A, et al. Graft versus host disease in a liver transplant patient with hepatitis B and hepatocellular carcinoma. Transplant Proc 1999;31:1890-1991.
27. Neumann UP, Kaisers U, Langrehr JM, Müller AR, Blumhardt G, Bechstein WO, et al. Fatal graft-versus-host-disease: a grave complication after orthotopic liver transplantation. Transplant Proc 1994;26:3616-3617.
28. Nikaein A, Collins RH, Klintmalm G, Poole T, Fay JW, Stone MJ. Immunologic monitoring of graft-versus-host disease following orthotopic liver transplantation. Transplantation 1994;57:637-640.
29. Pageaux GP, Perrigault PF, Fabre JM, Portales P, Souche B, Dereure O, et al. Lethal acute graft-versus-host disease in a liver transplant recipient: relations with cell migration and chimerism. Clin Transplant 1995;9:65-69.
30. Paizis G, Tait BD, Kyle P, Angus PW, Grigg AP. Successful resolution of severe graft versus host disease after liver transplantation correlating with disappearance of donor DNA from the peripheral blood. Aust NZ J Med 1998;28: 830-832.
31. Pollack MS, Speeg KV, Callander NS, Freytes CO, Espinoza AA, Esterl RM, et al. Severe, late-onset graft-versus-host disease in a liver transplant recipient documented by chimerism analysis. Hum Immunol 2005;66:28-31.
32. Redondo P, España A, Herrero JI, Quiroga J, Cienfuegos JA, Azanza JR, Prieto J. Graft-versus-host disease after liver transplantation. J Am Acad Dermatol 1993;29:314-317.
33. Riñón M, Maruri N, Arrieta A, Fernández; JR, Ortiz de Urbina J, García Masdevall MD. Selective immunosuppression with daclizumab in liver transplantation with graft-versus-host disease. Transplant Proc 2002;34:109-110.
34. Roberts JP, Ascher NL, Lake J, Capper J, Purohit S, Garovoy M, et al. Graft vs. host disease after liver transplantation in humans: a report of four cases. Hepatology 1991; 14:274-281.
35. Romagnuolo J, Jewell LD, Kneteman NM, Bain VG. Graft-versus-host disease after liver transplantation complicated by systemic aspergillosis with pancarditis. Can J Gastroenterol 2000; 14:637-640.
36. Rosen CB, Ng CS, Moore SB, Batts KP, Santrach PJ, Noel P, et al. Clinical and pathological features of graft-versus-host disease after liver transplantation: a case report and review of the literature. Clin Transplant 1993;7:52-58.
37. Sanchez-Izquierdo JA, Lumbreras C, Colina. F, Martinez-Laso J, Jiménez C, Gómez R, et al. Severe graft versus host disease following liver transplantation confirmed by PCR-HLA-B sequencing: report of a case and literature review. Hepatogastroenterology 1996;43:1057-1061.
38. Soejima Y, Shimada M, Suehiro T, Hiroshige S, Gondo H, Takami A, et al. Graft-versus-host disease following living donor liver transplantation. Liver Transpl 2004;10:460-464.
39. Starzl TE, Demetris AJ, Trucco M, Murase N, Ricordi C, Ildstad S, et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993;17:1127-1152.
40. Whalen JG, Jukic DM, English JC. Rash and pancytopenia as initial manifestations of acute graft-versus-host disease after liver transplantation. J Am Acad Dermatol 2005;52:908-912.
41. Perkins JD, Levy AE, Duncan JB, Carithers RL Jr. Using root cause analysis to improve survival in a liver transplant program. J Surg Res 2005; 129:6-16.
42. Kamei H, Oike F, Fujimoto Y, Yamamoto H, Tanaka K, Kiuchi T. Fatal graft-versus host disease after living donor liver transplantation: differential impact of donor-dominant one-way HLA matching. Liver Transpl 2006; 12:140-145.
43. Kiuchi T, Harada H, Matsukawa H, Kasahara M, Inomata Y, Uemoto S, et al. One-way donor-recipient HIA-matching as a risk factor for graft-versus-host disease in living-related liver transplantation. Transpl Int 1998; 11 (Suppl 1):S383-S384.
44. Leevy CB, Elbeshbeshy HA. Immunology of alcoholic liver disease. Clin Liver Dis 2005;9:55-66.
45. Laso FJ, Madruga JI, Lopez A, Ciudad J, Alvarez-Mon M, San Miguel J, et al. Distribution of peripheral blood lymphoid subsets in alcoholic liver cirrhosis: influence of ethanol intake. Alcohol Clin Exp Res 1996;29:1564-1568.
46. Hines IN, Wheeler MD. Recent advances in alcoholic liver disease. III. Role of the innate immune response in alcoholic hepatitis. Am J Physiol Gastrointest Liver Physiol 2004;287:G310-G314.
47. Pruett SB, Schwab C, Zheng Q, Fan R. Suppression of innate immunity by acute ethanol administration: a global perspective and a new mechanism beginning with inhibition of signaling through TLR3. J Immunol 2004; 173: 2715-2724.
48. + NKT cells. Cancer Res 1999;59: 5102-5105.
49. Wilson SB, Keknt SC, Patton KT, Orban T, Jackson RA, Exley M, et al. Extreme Th1 bias of invariant alpha24JalphaQ T cells in type 1 diabetes. Nature 1998; 391:177-181.
50. Kukreja A, Cost G, Marker J, Zhang C, Sun Z, Lin-Su K et al. Multiple immunoregulatory defects in type-1 diabetes. J Clin Invest 2002; 109:131-140.
51. Wilson SB, Kent SC, Horton HF, Hill AA, Bollyky PL, Hafler DA, et al. Multiple differences in gene expression in regulatory Valpha24,JalphaQ T cells from identical twins discordant for type I diabetes. Proc Natl Acad Sci USA 2000; 97:7411-7416.
52. Herder C, Kolb H, Koenig W, Haastert B, Muller-Scholze S, Rathmann W, et al. Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4). Diabetes Care 2006;29:368-371.
53. Sumida T, Sakamoto A, Murata H, Makino, Y, Takahashi H, Yoshida S, et al. Selective reduction of T cells bearing invariant Valpha24Jalpha Q antigen receptor in patients with systemic sclerosis. J Exp Med 1995; 182:1163-1168.
54. Kojo S, Adachi Y, Keino H, Taniguichi M, Sumida T. Dysfunction of T cell receptor AV24AJ18+, BV1I+ double-negative regulatory natural killer T cells in autoimmune diseases. Arthritis Rheum 2001;44:1127-1138.
55. Czaja AJ. Autoimmune liver disease. Curr Opin Gastroenterol 2006;22:234-240.
56. Farias AQ, Goncalves LL, Bittencourt PL, De Melo ES, Abrantes-Lemos CP, Porta G, et al. Applicability of the LAIHG scoring system to the diagnosis of antimitochondrial/anti-M2 seropositive variant form of autoimmune hepatitis. J Gastroenterol Hepatol 2006;21:887-893.
57. Longhi MS, Hussain MJ, Mitry RR, Arora SK, Mieli-Vergani G, Vergani D, Ma Y. Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol 2006 176:4484-4491.
58. Elinav E, Pappo O, Sklair-Levy M, Margalit M, Shibolet O, Gomori M, et al. Adoptive transfer of regulatory NKT lymphocytes ameliorates non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping. J Pathol 2006 209:121-128.